文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血患者中多重耐药菌的发生率及影响

Rate and impact of multidrug-resistant organisms in patients with aneurysmal subarachnoid hemorrhage.
PubMed 文献 · Acta Neurochir (Wien) · 2018-07-25

该研究回顾性分析了2010年11月至2017年8月在本机构收治的449例动脉瘤性蛛网膜下腔出血患者,首次描述了多重耐药菌(MDRO)的发生率及影响。MDRO阳性率为每100例患者4例,入院时患病率为每100例1.3例,获得率为每1000住院日1.1例。MDRO阳性与重症监护住院时间和总住院时间显著延长以及机械通气时间显著延长相关,但对出院时及随访时的格拉斯哥结局量表(GOS)评分无统计学显著影响。

要点

  • 449例动脉瘤性SAH患者中18例MDRO阳性,患病率为每100例4例。
  • MDRO阳性患者ICU住院时间及总住院时间显著延长,机械通气时间显著延长。
  • MDRO阳性对出院时及随访时GOS评分无统计学显著影响。

核心结论

  • MDRO阳性存在于4%的动脉瘤性SAH患者中,似乎与住院时间和机械通气时间延长相关,强调神经重症监护病房感染控制标准的重要性。

研究设计与样本

  • 回顾性研究,回顾了2010年11月至2017年8月在本机构收治的449例SAH患者的匿名数据,鉴定微生物学检测MDRO阳性的患者,MDRO筛查与国家建议一致。

主要发现

  • 449例SAH患者中18例MDRO阳性,患病率为每100例SAH患者4例;入院时患病率为每100例患者1.3例;获得率为每1000住院日1.1例。
  • MDRO阳性患者ICU住院时间均值±标准差为26.7±13.0天,非MDRO阳性患者为18.4±11.7天,p=0.004。
  • MDRO阳性患者住院时间均值±标准差为33.9±12.4天,非MDRO阳性患者为24.4±12.6天,p=0.002。
  • MDRO阳性患者机械通气时间中位数(IQR)为254.0(14.9-632.8)小时,非MDRO阳性患者为37.5(3.3-277.0)小时,p=0.02。
  • MDRO检测对出院时及随访(164.4±113.0天)时GOS评分无统计学显著影响。

临床怎么用

  • 原文强调神经重症监护病房感染控制标准的重要性,未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multidrug-resistant organisms (MDRO) are an increasing problem in critical care medicine. This study describes for the first time the rate and impact of MDRO in patients suffering from aneurysmal subarachnoid hemorrhage (SAH). METHODS: Anonymized data of SAH patients admitted to our institution from November 2010 to August 2017 were retrospectively reviewed. Patients with microbiological tests positive for MDRO were identified. Screening of MDRO was in consensus with national recommendations. RESULTS: 449 SAH patients were reviewed with 18 patients (prevalence: four MDRO-positive patients per 100 SAH patients) having positive tests for MDRO during their hospital stay. The prevalence upon admission was 1.3 MDRO-positive patients per 100 patients. The acquisition rate was 1.1 MDRO-positive patients per 1000 hospital days. Patients positive for an MDRO had a significantly extended length of stay in intensive care (mean ± SD 26.7 ± 13.0 versus 18.4 ± 11.7 days, p = 0.004) and in hospital (mean ± SD 33.9 ± 12.4 versus 24.4 ± 12.6 days, p = 0.002). MDRO detection was associated with a significant prolonged duration of mechanical ventilation (median (IQR) 254.0 (14.9-632.8) versus 37.5 (3.3-277.0) hours, p = 0.02). There was no statistically significant effect on the Glasgow Outcome Scale (GOS) at discharge and at follow-up after 164.4 ± 113.0 days. CONCLUSIONS: MDRO positivity is present in 4% of aneurysmal SAH patients. It seems to be associated with a prolonged length of stay and prolonged duration of mechanical ventilation. The importance of infection control standards in neurointensive care units is emphasized.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Mader MM, Grensemann J, Kluge S, et al. Rate and impact of multidrug-resistant organisms in patients with aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien). 2018. PMID: 30046875. doi:10.1007/s00701-018-3637-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。